166 related articles for article (PubMed ID: 27276516)
1. Successful use of eltrombopag for surgical preparation in a patient with ANKRD26-related thrombocytopenia.
Fiore M; Saut N; Alessi MC; Viallard JF
Platelets; 2016 Dec; 27(8):828-829. PubMed ID: 27276516
[No Abstract] [Full Text] [Related]
2. First successful use of eltrombopag before surgery in a child with MYH9-related thrombocytopenia.
Favier R; Feriel J; Favier M; Denoyelle F; Martignetti JA
Pediatrics; 2013 Sep; 132(3):e793-5. PubMed ID: 23940247
[TBL] [Abstract][Full Text] [Related]
3. Eltrombopag to allow chemotherapy in a patient with MYH9-related inherited thrombocytopenia and pancreatic cancer.
Paciullo F; Bury L; Gresele P
Int J Hematol; 2020 Nov; 112(5):725-727. PubMed ID: 32557126
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of severe thrombocytopenia with the use of thrombopoeitin receptor agonist eltrombopag in a patient with chronic myelomonocytic leukemia.
Modi Y; Shaaban H; Gauchan D; Maroules M
J Oncol Pharm Pract; 2015 Feb; 21(1):74-5. PubMed ID: 25063763
[TBL] [Abstract][Full Text] [Related]
5. Use of eltrombopag for the treatment of thrombocytopenia in hypoplastic myelodysplastic syndrome.
Gauchan D; Shaaban H; Gedeon D; Maroules M
Ann Hematol; 2014 Oct; 93(10):1777-8. PubMed ID: 24554304
[No Abstract] [Full Text] [Related]
6. Usage of eltrombopag for chronic immune thrombocytopenia as a pretreatment for splenectomy.
Uwagawa T; Misawa T; Furukawa K; Ito R; Futagawa Y; Yahagi Y; Aiba K; Yanaga K
Acta Haematol; 2013; 129(1):45-7. PubMed ID: 23128016
[No Abstract] [Full Text] [Related]
7. [Experience of off-label use of Eltrombopag in the treatment of thrombocytopenia associated with solid tumors].
García Lagunar MH; Cerezuela Fuentes P; Martínez Penella M; Gutiérrez-Meca Maestre DP; García Coronel M; Martínez Ortiz MJ
Farm Hosp; 2015 May; 39(3):157-60. PubMed ID: 26005891
[TBL] [Abstract][Full Text] [Related]
8. Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children.
Ali S; Gassas A; Kirby-Allen M; Krueger J; Ali M; Schechter T
Pediatr Transplant; 2017 Sep; 21(6):. PubMed ID: 28653480
[TBL] [Abstract][Full Text] [Related]
9. Eltrombopag in preparation for surgery in patients with severe MYH9-related thrombocytopenia.
Zaninetti C; Barozzi S; Bozzi V; Gresele P; Balduini CL; Pecci A
Am J Hematol; 2019 Aug; 94(8):E199-E201. PubMed ID: 31034630
[No Abstract] [Full Text] [Related]
10. Eltrombopag in thrombocytopenia.
Lawson A
N Engl J Med; 2008 Mar; 358(10):1072; author reply 1072-3. PubMed ID: 18322290
[No Abstract] [Full Text] [Related]
11. Analysis of clinical characteristics and treatment efficacy in two pediatric cases of
Pang C; Wu X; Nikuze L; Wei H
Platelets; 2023 Dec; 34(1):2262607. PubMed ID: 37852929
[No Abstract] [Full Text] [Related]
12. Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy.
Afdhal NH; Dusheiko GM; Giannini EG; Chen PJ; Han KH; Mohsin A; Rodriguez-Torres M; Rugina S; Bakulin I; Lawitz E; Shiffman ML; Tayyab GU; Poordad F; Kamel YM; Brainsky A; Geib J; Vasey SY; Patwardhan R; Campbell FM; Theodore D
Gastroenterology; 2014 Feb; 146(2):442-52.e1. PubMed ID: 24126097
[TBL] [Abstract][Full Text] [Related]
13. Eltrombopag for the Treatment of Severe Inherited Thrombocytopenia.
Abdelmoumen K; Fabre M; Ducastelle-Lepretre S; Favier R; Ballerini P; Bordet JC; Dargaud Y
Acta Haematol; 2021; 144(3):308-313. PubMed ID: 32987389
[TBL] [Abstract][Full Text] [Related]
14. Eltrombopag treatment for severe refractory thrombocytopenia caused by pembrolizumab.
Song P; Zhang L
Eur J Cancer; 2019 Nov; 121():4-6. PubMed ID: 31522129
[No Abstract] [Full Text] [Related]
15. Eltrombopag fails to improve severe thrombocytopenia in late-stage dyskeratosis congenita and diamond-blackfan-anaemia.
Trautmann K; Jakob C; von Grünhagen U; Schleyer E; Brümmendorf TH; Siegert G; Ehninger G; Platzbecker U
Thromb Haemost; 2012 Aug; 108(2):397-8. PubMed ID: 22739569
[No Abstract] [Full Text] [Related]
16. Eltrombopag use in a patient with Wiskott-Aldrich syndrome.
Gabelli M; Marzollo A; Notarangelo LD; Basso G; Putti MC
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28643468
[TBL] [Abstract][Full Text] [Related]
17. Molecule of the month. Eltrombopag.
Drug News Perspect; 2008; 21(6):344. PubMed ID: 18836592
[No Abstract] [Full Text] [Related]
18. Immune thrombocytopenia in two infant cases managed with eltrombopag.
Ceglie G; Nocentini G; De Gennaro F; Clemente V; Di Mauro M; Palumbo G
Pediatr Blood Cancer; 2021 Sep; 68(9):e29120. PubMed ID: 34047051
[No Abstract] [Full Text] [Related]
19. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.
McHutchison JG; Dusheiko G; Shiffman ML; Rodriguez-Torres M; Sigal S; Bourliere M; Berg T; Gordon SC; Campbell FM; Theodore D; Blackman N; Jenkins J; Afdhal NH;
N Engl J Med; 2007 Nov; 357(22):2227-36. PubMed ID: 18046027
[TBL] [Abstract][Full Text] [Related]
20. Eltrombopag for radiation-induced thrombocytopenia in a glioblastoma patient.
Duic JP; Grewal J; McConie K; Staszewski H; Haas J; Kesari S
J Neurooncol; 2012 Jan; 106(2):427-9. PubMed ID: 21833801
[No Abstract] [Full Text] [Related]
[Next] [New Search]
